Items where authors include "Saad, F."

Article

Parker, C.C. orcid.org/0000-0001-6512-124X, Petersen, P.M., Cook, A.D. orcid.org/0000-0003-4417-2632 et al. (55 more authors) (2024) Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047). Annals of Oncology, 35 (7). pp. 656-666. ISSN 0923-7534

Slovin, S., Hussain, S. orcid.org/0000-0003-1552-511X, Saad, F. et al. (11 more authors) (2019) Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer. Clinical Cancer Research, 25 (15). pp. 4624-4633. ISSN 1078-0432

Lipton, A., Smith, M.R., Fizazi, K. et al. (8 more authors) (2016) Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients With Advanced Cancer and Bone Metastases Treated With Bone Antiresorptive Agents. Clinical Cancer Research, 22 (23). pp. 5713-5721. ISSN 1078-0432

Lipton, A., Fizazi, K., Stopeck, A.T. et al. (12 more authors) (2016) Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics. EUROPEAN JOURNAL OF CANCER, 53. pp. 75-83. ISSN 0959-8049

Coleman, R.E. orcid.org/0000-0002-4275-1043, Lipton, A., Costa, L. et al. (9 more authors) (2013) Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features-An exploratory analysis of placebo-controlled trials. Journal of Bone Oncology, 2 (2). pp. 70-76. ISSN 2212-1366